Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James V Talwar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|July 30, 2024
GRIEVOUS: your command-line general for resolving cross-dataset genotype inconsistenciesJames V Talwar, Adam Klie, Meghana S Pagadala, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Epigenetic Germline Variants Predict Cancer Prognosis and Risk and Distribute Uniquely in Topologically Associating DomainsShervin Goudarzi, Meghana Pagadala, Adam Klie, et al.
F1000Research|January 26, 2026
Epigenetic germline variants predict cancer prognosis and risk and distribute uniquely in topologically associating domainsShervin Goudarzi, Meghana Pagadala, Adam Klie, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
VADEr: Vision Transformer-Inspired Framework for Polygenic Risk Reveals Underlying Genetic Heterogeneity in Prostate CancerJames V Talwar, Adam Klie, Meghana S Pagadala, et al.
Nature Computational Science|January 4, 2024
Predictive analyses of regulatory sequences with EUGENeAdam Klie, David Laub, James V Talwar, et al.
Journal of Immunotherapy and Precision Oncology|August 28, 2023
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant RelapseAndrea Castro, Aaron M Goodman, Zachary Rane, et al.
BMC Cancer|December 10, 2022
PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestryMeghana S Pagadala, Joshua A Linscott, James V Talwar, et al.
American Journal of Human Genetics|June 20, 2023
Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibilityJames V Talwar, David Laub, Meghana S Pagadala, et al.
Nature Communications|May 12, 2023
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy responseMeghana Pagadala, Timothy J Sears, Victoria H Wu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|July 30, 2024
GRIEVOUS: your command-line general for resolving cross-dataset genotype inconsistenciesJames V Talwar, Adam Klie, Meghana S Pagadala, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Epigenetic Germline Variants Predict Cancer Prognosis and Risk and Distribute Uniquely in Topologically Associating DomainsShervin Goudarzi, Meghana Pagadala, Adam Klie, et al.
F1000Research|January 26, 2026
Epigenetic germline variants predict cancer prognosis and risk and distribute uniquely in topologically associating domainsShervin Goudarzi, Meghana Pagadala, Adam Klie, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
VADEr: Vision Transformer-Inspired Framework for Polygenic Risk Reveals Underlying Genetic Heterogeneity in Prostate CancerJames V Talwar, Adam Klie, Meghana S Pagadala, et al.
Nature Computational Science|January 4, 2024
Predictive analyses of regulatory sequences with EUGENeAdam Klie, David Laub, James V Talwar, et al.
Journal of Immunotherapy and Precision Oncology|August 28, 2023
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant RelapseAndrea Castro, Aaron M Goodman, Zachary Rane, et al.
BMC Cancer|December 10, 2022
PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestryMeghana S Pagadala, Joshua A Linscott, James V Talwar, et al.
American Journal of Human Genetics|June 20, 2023
Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibilityJames V Talwar, David Laub, Meghana S Pagadala, et al.
Nature Communications|May 12, 2023
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy responseMeghana Pagadala, Timothy J Sears, Victoria H Wu, et al.
Pageof 1